Non-invasive technology for isolating Rare Circulating Cells
|ScreenCell® is a simple and innovative non-invasive technology for isolating Circulating Rare Cells (CRCs)from whole blood, and potentially any atypical cell in biological fluids.
By providing an easy access to fixed or live Circulating Tumor Cells (CTCs) and Circulating Tumor Microemboli (CTMs), the ScreenCell devices allow a full range access to phenotypical, genotypical, and functional characterization of these cells.
ScreenCell devices can also be used to isolate Circulating Fetal Cells (CFCs) in maternal peripheral blood for developing a new non-invasive approach to prenatal diagnosis.
|ScreenCell® is today the only system, which :
• is completely independent of any equipment
What ScreenCell® isolation devices help you do
ScreenCell®‘s unique advantages